scholarly journals Anaesthesia for Patients with Pericardial Disease

2019 ◽  
Author(s):  
Michelle Correia
Keyword(s):  
Pericardial Disease

Does tuberculous pericardial disease severity have distinct immunological features?

Pneumologie ◽  
2009 ◽  
Vol 63 (S 01) ◽  
Author(s):  
J Wolske ◽  
K van Veen ◽  
F Syed ◽  
J Russell ◽  
K Tibazarwa ◽  
...  
Keyword(s):  
Disease Severity ◽  
Pericardial Disease

Modern advances in cardiovascular imaging: cardiac computed tomography and cardiovascular MRI in pericardial disease

2014 ◽  
Vol 10 (6) ◽  
pp. 769-779 ◽  
Author(s):  
Chad W McRee ◽  
Patricia Mergo ◽  
Pragnesh Parikh ◽  
Amy Pollak ◽  
Brian P Shapiro
Keyword(s):  
Computed Tomography ◽  
Cardiac Computed Tomography ◽  
Cardiovascular Imaging ◽  
Cardiovascular Mri ◽  
Pericardial Disease

Pericardial disease

1989 ◽  
Vol 4 (3) ◽  
pp. 417-422 ◽  
Author(s):  
Guy S. Reeder
Keyword(s):  
Pericardial Disease

Abstract 13131: Cardiovascular Manifestations and Outcomes in Systemic Lupus Erythematosus: The Cleveland Clinic Contemporary Experience

Circulation ◽  
2020 ◽  
Vol 142 (Suppl_3) ◽  
Author(s):  
Tom Kai Ming Wang ◽  
Nicholas Chan ◽  
Mohamed Khayata ◽  
Patrick Flanagan ◽  
Richard A Grimm ◽  
...  
Keyword(s):  
Systemic Lupus Erythematosus ◽  
Lupus Erythematosus ◽  
Cleveland Clinic ◽  
Cardiac Events ◽  
Systemic Lupus ◽  
Pericardial Disease ◽  
Tertiary Referral Center ◽  
Multiple Organs ◽  
Ischemic Attack ◽  
Cardiac Manifestations

Background: Systemic lupus erythematosus (SLE) is an autoimmune connective tissue disease affecting multiple organs including the heart, which when affected portends poor prognosis. Given the advances in therapies and vigilance for cardiovascular screening for SLE patients, we evaluated the contemporary cardiovascular characteristics, manifestations and outcomes in SLE patients at our tertiary referral center. Methods: Consecutive patients from the prospective SLE bio-repository at our center between October 2012 and March 2020 were included. Cardiovascular data pertaining to manifestations, investigations, management and outcomes were collected. Results: 258 SLE patients were studied, with mean age 42.2 ± 14.7 years and 233 (90.3%) females. Cardio-respiratory symptoms were present in 92 (35.7%), most commonly dyspnea in 62 (24.0%) and chest pain in 53 (20.5%). Cardiac manifestations occurred in 97 (37.6%) patients, with pericardial disease in 38 (14.7%), valvular disease in 20 (7.8%), stroke/transient ischemic attack in 20 (7.8%), coronary heart disease in 17 (6.6%) and heart failure hospitalizations in 13 (5.0%) (Table 1). During a mean follow-up of 3.0 ± 2.2 years, there were 5 (1.9%) deaths, 19 (7.4%) developed cardiac events (table 1), 6 (2.3%) had cardiovascular procedures (3 cardiac surgeries, 2 percutaneous interventions and 1 device), and 44 (17.1%) had SLE-related hospitalizations. Conclusion: Cardiac manifestations remain prevalent in SLE, especially for pericardial, valvular and atherosclerotic diseases. With appropriate contemporary SLE and cardiovascular management, subsequent medium term adverse cardiovascular outcomes are low.

Sign in / Sign up

Export Citation Format

Share Document